Dr. Piatek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1441 Eastlake Ave
# NOR8302E
Los Angeles, CA 90089Phone+1 323-865-3105
Education & Training
University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 2012 - 2015
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2009 - 2012
Creighton University School of MedicineClass of 2009
Certifications & Licensure
CA State Medical License 2010 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA Start of enrollment: 2019 Apr 24
Publications & Presentations
PubMed
- 7 citationsFostamatinib for warm antibody autoimmune hemolytic anemia: Phase 3, randomized, double-blind, placebo-controlled, global study (FORWARD).David J Kuter, Caroline Piatek, Alexander Röth, Asif Siddiqui, Robert P Numerof
American Journal of Hematology. 2024-01-01 - 13 citationsPhase 3 Study of Subcutaneous Versus Intravenous Ravulizumab in Eculizumab-Experienced Adult Patients with PNH: Primary Analysis and 1-Year Follow-Up.Mustafa N Yenerel, Flore Sicre de Fontbrune, Caroline Piatek, Fahri Sahin, Wolfgang Füreder
Advances in Therapy. 2023-01-01 - 24 citationsOne-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab.Austin G. Kulasekararaj, Anita J. Hill, Saskia Langemeijer, Richard A. Wells, F. Ataúlfo González Fernández
European Journal of Haematology. 2021-01-03
Press Mentions
Rigel Reports First Quarter 2022 Financial Results and Provides Business UpdateMay 3rd, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
